At the IOR Institute of Oncology Research, research aims at improving our understanding of human cancer, a disease that greatly impacts on the everyday life of people around the world.
Our interests are focused on the genetics and the biology of cancer with a major emphasis on lymphomas and epithelial cancers, like prostate, breast and ovarian cancer. These studies aim to clarify the molecular mechanisms involved in the initiation and progression of human cancers and to shed light on the critical cellular regulatory processes.
Since the ultimate objective of our work is the improvement of the cure of patients affected by cancers, it is important for us to translate of our basic research into development of novel diagnostic, prognostic and therapeutic approaches.
Research activities at the IOR are formally organized into two main research programs: the first one is dedicated to solid tumors, such as prostate cancer, and the second deals with hematological diseases and lymphomas.
Researchers working in both programs integrate biological, genomics and molecular approaches with preclinical and translational studies to understand the disease and identify new treatment strategies.
Tumor Biology and Experimental Therapeutics
Lymphoma and Genomics